Biolinerx Ltd ADR (BLRX)

$0.64 0.04 (5.95%)

16:00 EDT BLRX Stock Quote Delayed 30 Minutes

BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023

By InvestorPlace Earnings Mar 26, 2024

BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023.

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

3 Tech Stocks That Wall Street Loves More Than Nvidia

3 Top Penny Stocks to Make You a Millionaire in 5 Years

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 423,242

Day's Range $0.62 - $0.68

52-Week Range $0.61 - $2.53

Dividend & Yield N/A (N/A)

BLRX Stock Predictions, Articles, and Biolinerx Ltd ADR News

From InvestorPlace
From the Web

3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now

By Ian Cooper, InvestorPlace Contributor Aug 7, 2023

One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors.

3 Smart Penny Stocks with Huge Potential

By Ian Cooper, InvestorPlace Contributor Jul 18, 2023

When it comes to investing in top penny stocks, a word of caution. Do your due diligence before buying. Make sure it has volume. And know…

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023

By Ian Cooper, InvestorPlace Contributor Jun 29, 2023

If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

The 3 Best Biotech Stocks Under $1 to Buy for April

By Ian Cooper, InvestorPlace Contributor Apr 4, 2023

While risky, here are some of the best biotech stocks under $1, with solid catalysts, investors may want to consider.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 20, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 1, 2021

Good morning, investor! We're starting the day off with a deep dive into the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer May 5, 2021

Here at InvestorPlace, we're starting the day off like we always do with a look at the biggest pre-market stock movers for Wednesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 4, 2021

Tuesday's here and with it another busy day of trading for investors as we look at the biggest pre-market stock movers of the day.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning

By William White, InvestorPlace Writer Apr 22, 2021

Thursday's here and we're taking a look at the biggest pre-market movers investors will want to know about before the opening bell.

BioLineRX News: Why BLRX Stock Is Skyrocketing Today

By Nick Clarkson, Web Editor Oct 30, 2020

BLRX stock is blasting off on Friday morning after the company reported strong results from a Phase-3 trial for one of its cancer treatments.

3 Cheap Biotech Stocks The Big Boys Are Buying (BLRX, OMED, FWP)

By May 15, 2017

Biotechnology is among the most exciting and lucrative sectors for investors, and these 3 biotech stocks stand out...

7 Biotechnology Stocks to Buy Now

By Portfolio Grader Jul 1, 2015

Seven biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Best Stocks Under $5 This Week

By Ethan Roberts, InvestorPlace Contributor Jun 26, 2015

A better week for small priced stocks saw Turtle Beach, Internet Patents, Kelso Technologies, Bioline RX and Penn Virginia making giant leaps in price.

BioLineRx files for a $250M mixed securities shelf (NASDAQ:BLRX)

From Seeking Alpha Dec 29, 2023

BioLineRx (BLRX) has filed a prospectus for a mixed shelf offering to raise up to $250M, indicating potential growth in their financial capital.

biolinerx GAAP EPS of -$0.01 (NASDAQ:BLRX)

From Seeking Alpha Nov 20, 2023

BiolineRx, a biopharmaceutical company, reports Q3 2023 financial results, with a GAAP EPS of -$0.01.

BioLineRx announces closing of exclusive license agreement with GloriaBio (NASDAQ:BLRX)

From Seeking Alpha Oct 12, 2023

BioLineRx announced a license agreement with GloriaBio for the development of motixafortide in Asia, including potential milestones and equity investment.

BioLineRx stock gains after first FDA approval (NASDAQ:BLRX)

From Seeking Alpha Sep 11, 2023

BioLineRx (BLRX) added ~23% pre-market Monday after the FDA greenlighted its lead asset Aphexda (motixafortide) for multiple myeloma patients. Read more here.

BioLineRX anti-tumor vaccine shows promise in early-stage trial (NASDAQ:BLRX)

From Seeking Alpha Dec 20, 2022

AGI-134, an intratumoral cancer vaccine candidate from BioLineRX (BLRX), demonstrated safety and tolerability in a phase 1/2a trial.

Bioline RX Ltd Sponsored ADR (BLRX) Receives a Buy from H.C. Wainwright

From TipRanks Nov 15, 2022

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Bioline RX Ltd Sponsored ADR (BLRX – Research Report) today and set a price target of $19....

Biolinerx Ltd ADR (BLRX)

BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

3 Tech Stocks That Wall Street Loves More Than Nvidia

3 Top Penny Stocks to Make You a Millionaire in 5 Years

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Biolinerx Ltd ADR (BLRX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BLRX Stock Predictions, Articles, and Biolinerx Ltd ADR News

Subscriber Sign in